Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
EDIT holding history
Editas Medicine, Inc. in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EDIT overviewAll 13F holders of EDITFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −19,353−100.0% | Sold out | Holders |
| Q1 2022 | 19,353 | $368.0K | <0.1% | +4,575+31.0% | Added | Holders |
| Q4 2021 | 14,778 | $392.0K | <0.1% | +1,803+13.9% | Added | Holders |
| Q3 2021 | 12,975 | $533.0K | <0.1% | −30−0.2% | Reduced | Holders |
| Q2 2021 | 13,005 | $737.0K | <0.1% | −45−0.3% | Reduced | Holders |
| Q1 2021 | 13,050 | $548.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.